Methods and compositions for treating polycystic ovary syndrome

Details for Australian Patent Application No. 2003205135 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Hathaway, David, R.

Agent Spruson & Ferguson

Pub. Number AU-B-2003205135

PCT Number PCT/US03/01109

PCT Pub. Number WO2003/061362

Priority 60/350,395 22.01.02 US; 10/317,126 11.12.02 US

Filing date 14 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 17 January 2008

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/047 (2006.01)

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 31/585 (2006.01)

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/28 (2006.01) Drugs for disorders of the endocrine system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/14 Drugs for dermatological disorders

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/350,395 22.01.02 US; 10/317,126 11.12.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003205135

17 January 2008 Application Accepted

  Published as AU-B-2003205135

15 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003205136-Method and apparatus for dynamically assigning a network endpoint to a network region

2003205134-MULTILAYER THERMAL BARRIER COATING